[1] Mohan B P, Meyyur Aravamudan V, Khan S R, et al. Prevalence of colorectal cancer in cryptogenic pyogenic liver abscess patients. Do they need screening colonoscopy? A systematic review and meta-analysis[J]. Dig Liver Dis, 2019, 51(12): 1641-1645. [2] Suzuki H, Kidder I, Tanaka T, et al. Incidence of colorectal cancer in patients diagnosed with pyogenic liver abscess[J]. JAMA Netw Open, 2023, 6(12): e2348218. [3] Kumar R, Patel R, Priyadarshi R N, et al. Amebic liver abscess: an update[J]. World J Hepatol, 2024, 16(3): 316-330. [4] Lyu Y, Wang B. Prognostic risk factors for pyogenic liver abscess caused by Klebsiella pneumoniae[J]. BMC Gastroenterol, 2024, 24(1): 298. [5] Yang L L, Ma Z X, Li C, et al. Clinical significance of the combined detection of procalcitonin and platelet on the diagnosis and prognosis of sepsis[J]. Lab Med Clin, 2016, 13(19): 2752-2754. [6] Yang X Y, Li R, Liu W C. Predictive value of plateletcrit combined with systolic blood pressure and APACHE Ⅱ score in septic shock[J]. J Med Res, 2023, 52(10): 160-163+121. [7] Niu K X, Wu S L, Liu C, et al. Clinical value of serum amyloid A and interleukin-6 in the diagnosis and severity evaluation of sepsis[J]. Chin J Gen Pract, 2022, 20(9): 1484-1487. [8] Frimpong A, Owusu E D A, Amponsah J A, et al. Cytokines as potential biomarkers for differential diagnosis of sepsis and other non-septic disease conditions[J]. Front Cell Infect Microbiol, 2022, 12: 901433. [9] Cho A R, Lee T H, Park M J, et al. Septic shock in pyogenic liver abscess: clinicalconsiderations[J]. Korean J Gastroenterol, 2016, 67(5): 245-252. [10] 朱国方,高俊,沈琦.糖尿病合并肝脓肿患者血糖控制水平与临床及CT影像特征相关性分析[J].中国现代医生,2023,61(30):47-50+55. [11] Wang M, Qian G, Xiao H, et al. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-Ⅱ after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients[J]. Oncologist, 2024, 29(12): e1723-e1733. [12] Qi F, Zhou A, Yan L, et al. The diagnostic value of PIVKA-Ⅱ, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma[J]. J Clin Lab Anal, 2020, 34(5): e23158. [13] Liu Z, Du X H, Chai W G. Efficacy of des-γ-carboxy-prothrombin in the diagnosis of hepatocellular carcinoma and its association with the clinical features of hepatocellular carcinoma[J]. J Clin Hepatol, 2024, 40(10): 2014-2018. [14] Wei F Y, Ruan X L, Meng J Y, et al. The value of combined detection of PLT, PIVKA-Ⅱ and Alb in the differential diagnosis of AFP-negative hepatocellular carcinoma and cirrhosis[J]. Lab Med Clin, 2024, 21(15): 2155-2158. [15] Huang C F, Kroeniger K, Wang C W, et al. Surveillance imaging and GAAD/GALAD scores for detection of hepatocellular carcinoma in patients with chronic hepatitis[J]. J Clin Transl Hepatol, 2024, 12(11): 907-916. [16] Lai Z L, Wang E L, Wu L S. Value of alpha-fetoprotein combined with abnormal prothrombin detection in early diagnosis of liver cancer[J]. J Rare Uncommon Dis, 2024, 31(8): 67-68. [17] Guo N, Sun M Z, Miao Y Y. Analysis of the diagnostic value of abnormal prothrombin Ⅱ and alpha-fetoprotein combined detection in primary liver cancer[J]. Syst Med, 2024, 9(12): 171-174. [18] Liu X W, Yang C Y, Liu X P, et al. Sarcomatoid hepatocellular carcinoma with subdiaphragmatic metastasis misdiagnosed as liver abscess: a case report[J]. Medicine (Baltimore), 2024, 103(49): e40842. [19] Gao B, Liu Y, Duan W. Sarcomatoid hepatocellular carcinoma: a Case report and review of literature[J]. Clin Case Rep, 2025, 13(2): e70195. [20] 辛宇超.240例细菌性肝脓肿的临床特征[D].长春:吉林大学,2024. [21] 胡爱玲,孙超,王娜,等.肝脓肿病原菌分布、耐药性及并发脓毒症风险预测模型的构建[J].安徽医药,2025,29(7):1399-1405. [22] 刘槿晴.细菌性肝脓肿临床特点及病原学特征分析[D].长沙:中南大学,2022. [23] Long Q, Zhao X Y, Chen C, et al. Liver abscesses caused by streptococcus: report of 21 cases[J]. Chin J Infect Chemother, 2025, 25(3): 272-278. [24] Liu F, Zhu H D. Analysis of the status of invasive liver abscess syndrome caused by Klebsiella pneumoniae infection[J]. Syst Med, 2020, 5(5): 190-192. [25] Amulele A V, Ong'ayo G, Arara A M, et al. Recurrent spontaneous Escherichia coli meningitis in an adult: a case report[J]. JAC Antimicrob Resist, 2023, 5(2): dlad029. [26] Davis K, Abo Y N, Steer A C, et al. Chains of misery: surging invasive group A streptococcal disease[J]. Curr Opin Infect Dis, 2024, 37(6): 485-493. [27] Martín-Delgado M C, De Lucas Ramos P, García-Botella A, et al. Invasive group A Streptococcus infection (Streptococcus pyogenes): current situation in Spain[J]. Rev Esp Quimioter, 2024, 37(6): 454-471. [28] Manuel G, Twentyman J, Noble K, et al. Group B streptococcal infections in pregnancy and early life[J]. Clin Microbiol Rev, 2025, 38(1): e0015422. [29] Li Y, Yang W, Li Y, et al. The increasing burden of group B Streptococcus from 2013 to 2023: a retrospective cohort study in Beijing, China[J]. Microbiol Spectr, 2025, 13(1): e0226624. [30] Uggen E, Olaisen C, Lyng R V, et al. Incidence of invasive infections with Group B streptococcus in adults in Norway 1996-2019: a nationwide registry-based case-control study[J]. Infection, 2024, 52(5): 1745-1752. [31] 扈东营.侵袭性念珠菌感染患者致病菌菌种分布及体外药敏分析[D].上海:中国人民解放军海军军医大学,2022. [32] Wang H, Chen S M, Li X, et al. Clinical characteristics and antibiotic sensitivity analysis of the invasive yeast infection[J]. Chin J Antibiot, 2024, 49(10): 1095-1100. |